SG11202001754RA - Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof - Google Patents
Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereofInfo
- Publication number
- SG11202001754RA SG11202001754RA SG11202001754RA SG11202001754RA SG11202001754RA SG 11202001754R A SG11202001754R A SG 11202001754RA SG 11202001754R A SG11202001754R A SG 11202001754RA SG 11202001754R A SG11202001754R A SG 11202001754RA SG 11202001754R A SG11202001754R A SG 11202001754RA
- Authority
- SG
- Singapore
- Prior art keywords
- sigirr
- variants
- receptor related
- single immunoglobulin
- interleukin
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 102000045959 Interleukin-1 Receptor-Like 1 Human genes 0.000 title 1
- 108700003107 Interleukin-1 Receptor-Like 1 Proteins 0.000 title 1
- 101150034627 SIGIRR gene Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762554857P | 2017-09-06 | 2017-09-06 | |
| PCT/US2018/049478 WO2019050899A1 (en) | 2017-09-06 | 2018-09-05 | Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202001754RA true SG11202001754RA (en) | 2020-03-30 |
Family
ID=63708447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202001754RA SG11202001754RA (en) | 2017-09-06 | 2018-09-05 | Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210071251A1 (en) |
| EP (1) | EP3679158A1 (en) |
| JP (1) | JP7237064B2 (en) |
| KR (1) | KR20200058435A (en) |
| CN (1) | CN111373053A (en) |
| AU (1) | AU2018328120A1 (en) |
| CA (1) | CA3074652A1 (en) |
| IL (1) | IL272940B1 (en) |
| MX (1) | MX2020002643A (en) |
| SG (1) | SG11202001754RA (en) |
| WO (1) | WO2019050899A1 (en) |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US5294533A (en) | 1988-07-05 | 1994-03-15 | Baylor College Of Medicine | Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
| US5135917A (en) | 1990-07-12 | 1992-08-04 | Nova Pharmaceutical Corporation | Interleukin receptor expression inhibiting antisense oligonucleotides |
| US5271941A (en) | 1990-11-02 | 1993-12-21 | Cho Chung Yoon S | Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases |
| US5786138A (en) | 1993-01-29 | 1998-07-28 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Hyperstabilizing antisense nucleic acid binding agents |
| ATE196313T1 (en) | 1993-06-04 | 2000-09-15 | Us Health | METHOD FOR TREATING KAPOSI-SARCOMA WITH ANTISENSE OLIGONUCLEOTIDES |
| US5578716A (en) | 1993-12-01 | 1996-11-26 | Mcgill University | DNA methyltransferase antisense oligonucleotides |
| US5641754A (en) | 1994-01-10 | 1997-06-24 | The Board Of Regents Of The University Of Nebraska | Antisense oligonucleotide compositions for selectively killing cancer cells |
| WO1996005298A1 (en) | 1994-08-09 | 1996-02-22 | Ciba-Geigy Ag | Antitumor antisense oligonucleotides |
| US5856103A (en) | 1994-10-07 | 1999-01-05 | Board Of Regents The University Of Texas | Method for selectively ranking sequences for antisense targeting |
| US5994320A (en) | 1995-02-06 | 1999-11-30 | Regents Of The University Of Minnesota | Antisense oligonucleotides and methods for treating central nervous system tumors |
| IT1275862B1 (en) | 1995-03-03 | 1997-10-24 | Consiglio Nazionale Ricerche | ANTI-SENSE TRANSCRIPT ASSOCIATED WITH SOME TYPES OF TUMOR CELLS AND SYNTHETIC OLIGODEOXYNUCLEOTIDES USEFUL IN DIAGNOSIS AND TREATMENT |
| US6040296A (en) | 1995-06-07 | 2000-03-21 | East Carolina University | Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation |
| WO1997014709A1 (en) | 1995-10-13 | 1997-04-24 | F. Hoffmann-La Roche Ag | Antisense oligomers |
| EA000841B1 (en) | 1995-11-21 | 2000-04-24 | Ай-Си-Эн ФАРМАСЬЮТИКАЛЗ | Antisense oligonucleotides for il-8 and il-8 receptor and method ot treating cancer |
| CA2246503A1 (en) | 1996-02-15 | 1997-08-21 | National Institutes Of Health | Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| US5955590A (en) | 1996-07-15 | 1999-09-21 | Worcester Foundation For Biomedical Research | Conjugates of minor groove DNA binders with antisense oligonucleotides |
| US6046004A (en) | 1997-02-27 | 2000-04-04 | Lorne Park Research, Inc. | Solution hybridization of nucleic acids with antisense probes having modified backbones |
| JPH1142091A (en) | 1997-07-25 | 1999-02-16 | Toagosei Co Ltd | Anti-sense nucleic acid compound |
| CA2248762A1 (en) | 1997-10-22 | 1999-04-22 | University Technologies International, Inc. | Antisense oligodeoxynucleotides regulating expression of tnf-.alpha. |
| WO1999032626A1 (en) | 1997-12-23 | 1999-07-01 | Immunex Corporation | Sigirr dna and polypeptides |
| US6007995A (en) | 1998-06-26 | 1999-12-28 | Isis Pharmaceuticals Inc. | Antisense inhibition of TNFR1 expression |
| US6013522A (en) | 1999-02-23 | 2000-01-11 | Isis Pharmaceuticals Inc. | Antisense inhibition of human Smad1 expression |
| US6025198A (en) | 1999-06-25 | 2000-02-15 | Isis Pharmaceuticals Inc. | Antisense modulation of Ship-2 expression |
| US6033910A (en) | 1999-07-19 | 2000-03-07 | Isis Pharmaceuticals Inc. | Antisense inhibition of MAP kinase kinase 6 expression |
| JP6343605B2 (en) | 2012-05-25 | 2018-06-13 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Methods and compositions for RNA-dependent target DNA modification and RNA-dependent transcriptional regulation |
| ES2769310T3 (en) | 2012-12-06 | 2020-06-25 | Sigma Aldrich Co Llc | Modification and regulation of the genome based on CRISPR |
| WO2018022967A1 (en) | 2016-07-28 | 2018-02-01 | Regeneron Pharmaceuticals, Inc. | Gpr156 variants and uses thereof |
-
2018
- 2018-09-05 IL IL272940A patent/IL272940B1/en unknown
- 2018-09-05 JP JP2020513609A patent/JP7237064B2/en active Active
- 2018-09-05 WO PCT/US2018/049478 patent/WO2019050899A1/en active Application Filing
- 2018-09-05 AU AU2018328120A patent/AU2018328120A1/en active Pending
- 2018-09-05 SG SG11202001754RA patent/SG11202001754RA/en unknown
- 2018-09-05 CN CN201880071851.1A patent/CN111373053A/en active Pending
- 2018-09-05 KR KR1020207009809A patent/KR20200058435A/en not_active Application Discontinuation
- 2018-09-05 CA CA3074652A patent/CA3074652A1/en active Pending
- 2018-09-05 EP EP18779488.8A patent/EP3679158A1/en active Pending
- 2018-09-05 US US16/644,650 patent/US20210071251A1/en active Pending
- 2018-09-05 MX MX2020002643A patent/MX2020002643A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2020112474A (en) | 2021-10-06 |
| WO2019050899A1 (en) | 2019-03-14 |
| CN111373053A (en) | 2020-07-03 |
| IL272940A (en) | 2020-04-30 |
| AU2018328120A1 (en) | 2020-03-19 |
| JP7237064B2 (en) | 2023-03-10 |
| MX2020002643A (en) | 2020-09-25 |
| RU2020112474A3 (en) | 2021-12-29 |
| CA3074652A1 (en) | 2019-03-14 |
| EP3679158A1 (en) | 2020-07-15 |
| KR20200058435A (en) | 2020-05-27 |
| JP2020537495A (en) | 2020-12-24 |
| US20210071251A1 (en) | 2021-03-11 |
| IL272940B1 (en) | 2024-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274921A (en) | Bcma-targeting chimeric antigen receptor, and uses thereof | |
| ZA201808623B (en) | Glucocorticoid receptor agonist and immunoconjugates thereof | |
| IL280718A (en) | T cell receptor constructs and uses thereof | |
| HK1252009A1 (en) | Antibodies directed against interleukin 36 receptor (il-36r) | |
| IL276950A (en) | Anti-cd73 antibodies and uses thereof | |
| IL247459B (en) | Anti human interleukin-1 receptor accessory protein (il1 rap) antibodies and uses thereof | |
| IL282968A (en) | Anti-nkg2a antibodies and uses thereof | |
| EP3573104A4 (en) | Light-receiving element, imaging element and imaging device | |
| ZA202003325B (en) | Glucocorticoid receptor agonist and immunoconjugates thereof | |
| ZA202002966B (en) | T-cell receptor (tcr)-binding antibodies and uses thereof | |
| IL276746A (en) | Kir3dl3 as an hhla2 receptor, anti-hhla2 antibodies, and uses thereof | |
| IL275826A (en) | Anti-mct1 antibodies and uses thereof | |
| IL281297A (en) | Anti-npr1 antibodies and uses thereof | |
| ZA201906954B (en) | Btla agonist antibodies and uses thereof | |
| IL280321A (en) | Anti-cxcr2 antibodies and uses thereof | |
| IL277330A (en) | Anti-il-27 antibodies and uses thereof | |
| IL283875A (en) | Anti-il-27 antibodies and uses thereof | |
| IL281202A (en) | Anti-tnfrsf9 antibodies and uses thereof | |
| IL277075A (en) | Anti-phf-tau antibodies and uses thereof | |
| IL276548A (en) | Bcma-binding antibodies and uses thereof | |
| IL283926A (en) | Anti-alpha-synuclein antibodies and uses thereof | |
| IL283890A (en) | Anti-periostin antibodies and uses thereof | |
| GB2585607B (en) | Chimeric antigen receptor and application thereof | |
| IL272940A (en) | Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof | |
| IL279790A (en) | Anti-l1cam antibodies and uses thereof |